Matrix Metalloproteinase-2 Is an Interstitial Collagenase

INHIBITOR-FREE ENZYME CATALYZES THE CLEAVAGE OF COLLAGEN FIBRILS AND SOLUBLE NATIVE TYPE I COLLAGEN GENERATING THE SPECIFIC ¾- AND ¼-LENGTH FRAGMENTS (*)

  1. Ronald T. Aimes(1)(§) and
  2. James P. Quigley(2)(¶)
  1. From the (1)Department of Biochemistry and Cell Biology and
  2. (2)Department of Pathology, State University of New York, Stony Brook, New York 11794
  1. To whom correspondence should be addressed. Tel.: 516-444-3014; Fax: 516-444-3424.

Abstract

The 72-kDa gelatinase/type IV collagenase (MMP-2) is a member of the matrix metalloproteinase (MMP) family of enzymes. This enzyme is known to cleave type IV collagen as well as degrade denatured collagens. However, native interstitial collagens are reportedly resistant to MMP-2 and are thought to be susceptible only to the interstitial collagenases MMP-1 and MMP-8. In this study we report that both human and chicken MMP-2, free of tissue inhibitors of metalloproteinases (TIMPs) are capable of cleaving soluble, triple helical type I collagen generating the ¾- and ¼-length collagen fragments characteristic of vertebrate interstitial collagenases. MMP-2 cleaves at the same Gly-Ile/Leu bond in the collagen α chains as interstitial collagenases with kGraphic and KGraphic values similar to that of MMP-1. MMP-2 also is capable of degrading reconstituted type I collagen fibrils. The closely related 92-kDa gelatinase/type IV collagenase (MMP-9) is unable to cleave soluble or fibrillar collagen under identical conditions indicating that the specific collagenolytic activity of MMP-2 is not a general property of gelatinases. That MMP-2, a potent gelatinase, also can cleave fibrillar collagen provides an alternative to the proposal that two enzymes, an interstitial collagenase and a gelatinase, are required for the complete dissolution of stromal collagen during cellular invasion.

Footnotes

  • § Institute for Cell and Developmental Biology predoctoral scholar supported by a fellowship from Merck and Company.

  • * This work was supported in part by United States Public Health Service Grant CA 55852 (to J. P. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    ECM

    extracellular matrix

    MMP

    matrix metalloproteinase

    TIMP

    tissue inhibitor of metalloproteinases

    APMA

    p-aminophenylmercuric acetate

    PAGE

    polyacrylamide gel electrophoresis

    TC

    tropocollagen

    TPCK

    L-1-tosylamido-2-phenylethyl chloromethyl ketone.

    • Received November 18, 1994.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement